High or Low Dose Syntocinon (Oxytocin) for delay in labour

ISRCTN ISRCTN23847193
DOI https://doi.org/10.1186/ISRCTN23847193
EudraCT/CTIS number 2009-012752-24
Secondary identifying numbers 8896
Submission date
29/10/2010
Registration date
29/10/2010
Last edited
28/05/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Ms Deborah Bird
Scientific

Department of Public Health and Epidemiology
Edgbaston
Birmingham
B15 2TT
United Kingdom

Phone +44 121 414 6754
Email d.bird@bham.ac.uk

Study information

Study designMulticentre randomised interventional treatment trial with an observational qualitative element
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleHigh or Low Dose Syntocinon (Oxytocin) for delay in labour
Study acronymHOLDS
Study objectivesUse of high dose oxytocin will achieve more effective uterine contractions resulting not only in shorter labours but in a higher chance of vaginal birth in women who are diagnosed as having delay in the first stage of labour.
Ethics approval(s)23/06/2010 (ref: 10/H0406/30)
Health condition(s) or problem(s) studiedTopic: Reproductive Health and Childb; Subtopic: Reproductive Health and Childb (all Subtopics); Disease: Reproductive Health & Childbirth
InterventionSyntocinon, 10 IU versus 20 IU

Study entry: single randomisation only
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Syntocinon (Oxytocin)
Primary outcome measureBirth and early postnatal period
Secondary outcome measuresNot provided at time of registration
Overall study start date01/11/2010
Completion date30/09/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexFemale
Target number of participantsPlanned sample size: 100; UK sample size: 100
Total final enrolment94
Key inclusion criteria1. Consenting nulliparous women with a singleton pregnancy at term (37 - 42 weeks) gestation
2. Confirmed delay in labour as defined by NICE Intrapartum Care Guideline and with ruptured membranes
3. Labour is established when there are regular painful contractions and progressive cervical dilation from 4 cm. Delay is suspected when cervical dilatation of less than 2 cm in 4 hours occurs once labour is established. Delay is confirmed when progress of less than 1 cm in 2 hours is found on repeat vaginal examination.
Key exclusion criteria1. Under 16 years old
2. Induction
3. Body mass index (BMI) greater than 40
4. Multiple pregnancy
5. Existing maternal or fetal disease or concern
6. Gestational diabetes
7. Previous uterine surgery
8. Vaginal bleeding in this pregnancy of clinical significance
9. Contra-indication to oxytocin therapy
Date of first enrolment01/11/2010
Date of final enrolment30/09/2011

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Public Health and Epidemiology
Birmingham
B15 2TT
United Kingdom

Sponsor information

University of Birmingham (UK)
University/education

Department of Public Health and Epidemiology
Edgbaston
Birmingham
B15 2TT
England
United Kingdom

Website http://www.staff.bham.ac.uk/
ROR logo "ROR" https://ror.org/03angcq70

Funders

Funder type

Government

National Institute for Health Research (NIHR) (UK) - Research for Patient Benefit (RfPB) Programme

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Basic results 28/05/2020 No No
HRA research summary 28/06/2023 No No

Editorial Notes

28/05/2020: The following changes were made to the trial record:
1.Added clinicaltrialsregister.eu link to basic results (scientific).
2. The total final enrollment was added.
11/05/2017: No publications found in PubMed, verifying study status with principal investigator